Chengdu Hualin Baitai Technology Co., Ltd. – Trademark Portfolio

Entity Type: 99

Chengdu Hualin Baitai Technology Co., Ltd. holds 1 U.S. trademark filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 10 (Medical Apparatus) — 1 filings in this category. Currently, 1 trademark is registered. Notable registered marks include EUYIHLYBT. The owner is based in Chengdu, Sichuan.

No. 118 Weijianian 1st Rd.,Jinniu Dist.,

No. 33, 9F, Building 3,

Chengdu, Sichuan 610036 , CN

1 Total Trademarks

Add to watchlist:

No watchlists yet
Loading...
By Date
By Name
Filter by Class:

EUYIHLYBT
EUYIHLYBT
Registered 2024

Trademark Classifications

Chengdu Hualin Baitai Technology Co., Ltd.'s trademark portfolio spans 1 Nice Classification class, reflecting the scope of goods and services protected under their brand portfolio.

10
Medical Apparatus (1 filing)

Surgical, medical, dental and veterinary apparatus and instruments

Frequently Asked Questions

How many trademarks does Chengdu Hualin Baitai Technology Co., Ltd. have?

Chengdu Hualin Baitai Technology Co., Ltd. has 1 U.S. trademark filed with the USPTO. Of these, 1 registered.

What trademark classes does Chengdu Hualin Baitai Technology Co., Ltd. file in?

Chengdu Hualin Baitai Technology Co., Ltd. files trademarks across 1 Nice Classification class. The most active classes are Class 10 (Medical Apparatus). Class 10 covers surgical, medical, dental and veterinary apparatus and instruments.

What are Chengdu Hualin Baitai Technology Co., Ltd.'s most well-known trademarks?

Chengdu Hualin Baitai Technology Co., Ltd.'s registered trademark portfolio includes well-known marks such as EUYIHLYBT. These are among 1 currently registered trademark in the portfolio.

What is Chengdu Hualin Baitai Technology Co., Ltd.'s trademark registration success rate?

Chengdu Hualin Baitai Technology Co., Ltd. has a 100% trademark registration rate, with 1 out of 1 resolved applications resulting in successful registration. Currently, 0 applications are pending review.